Synthetic Melanin Acts as Efficient Peptide Carrier in Cancer Vaccine Strategy

We previously reported that a novel peptide vaccine platform, based on synthetic melanin nanoaggregates, triggers strong cytotoxic immune responses and significantly suppresses tumor growth in mice. However, the mechanisms underlying such an efficacy remained poorly described. Herein, we investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuzzubbo, Stefania, Roch, Benoit, Darrasse-Jèze, Guillaume, Hosten, Benoit, Leclercq, Manon, Vignal, Nicolas, Banissi, Claire, Tartour, Eric, Carpentier, Antoine F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738778/
https://www.ncbi.nlm.nih.gov/pubmed/36499300
http://dx.doi.org/10.3390/ijms232314975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738778/
https://www.ncbi.nlm.nih.gov/pubmed/36499300
http://dx.doi.org/10.3390/ijms232314975

Ejemplares similares